[Possibilities for inactivation of protease activity in sputum by protease inhibitors in chronic obstructive airway diseases].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000402:Airway Obstruction / Q000201:enzymology*; D000510:Alpha-Globulins / Q000494:pharmacology; D007611:Aprotinin / Q000494:pharmacology; D001980:Bronchi / Q000201:enzymology; D002648:Child; D002908:Chronic Disease; D006801:Humans; D008875:Middle Aged; D010936:Plant Extracts / Q000494:pharmacology; D011480:Protease Inhibitors; D012712:Serum Globulins / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013025:Glycine max; D013183:Sputum / Q000187:drug effects*; D013885:Thiosulfates / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000510:Alpha-Globulins; D010936:Plant Extracts; D011480:Protease Inhibitors; D012712:Serum Globulins; D013885:Thiosulfates; D014361:Trypsin Inhibitors; D007611:Aprotinin; D012964:Sodium
Uber die Möglichkeiten der Inaktivierung der Proteaseaktivität im Sputum bei chronisch obstruktiven Atemwegserkrankungen durch Proteaseinhibitoren.